StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report sent to investors on Friday morning. The firm issued a hold rating on the stock.
China Pharma Trading Down 3.7 %
Shares of CPHI stock opened at $0.24 on Friday. China Pharma has a 1-year low of $0.17 and a 1-year high of $1.21. The company has a current ratio of 0.84, a quick ratio of 0.24 and a debt-to-equity ratio of 0.19. The stock’s fifty day simple moving average is $0.21 and its 200-day simple moving average is $0.27.
China Pharma (NYSE:CPHI – Get Free Report) last issued its quarterly earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%. The business had revenue of $0.93 million for the quarter.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Articles
- Five stocks we like better than China Pharma
- Transportation Stocks Investing
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- Comparing and Trading High PE Ratio Stocks
- CarMax’s Impressive Rally: What Investors Should Watch Next
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MarketBeat Week in Review – 9/23 – 9/27
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
